Effect of Body Mass Index on Lung Function in Chinese Patients with Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study
Jing Zhu,Zhiling Zhao,Bin Wu,Zhihong Shi,Qingrong Nie,Zhen Fu,Zhaofu Zeng,Weihua Hu,Minglin Dong,Mengqing Xiong,Ke Hu
DOI: https://doi.org/10.2147/COPD.S265676
2020-10-13
International Journal of COPD
Abstract:Jing Zhu, 1, 2, * Zhiling Zhao, 3, * Bin Wu, 4 Zhihong Shi, 5 Qingrong Nie, 6 Zhen Fu, 7 Zhaofu Zeng, 1 Weihua Hu, 1 Minglin Dong, 1 Mengqing Xiong, 1 Ke Hu 1 1 Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, The People's Hospital of China Three Gorges University, Yichang, Hubei, People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China; 4 Institute of Respiratory Diseases, Department of Respiratory, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China; 5 Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Xian Jiaotong University, Xian, Shanxi, People's Republic of China; 6 Division of Respiratory Disease, Liangxiang Hospital of Yanjing Medical College, Capital Medical University, Beijing, People's Republic of China; 7 Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China *These authors contributed equally to this work Correspondence: Ke Hu Email huke-rmhospital@163.com Objective: The aim of this study was to explain "obesity paradox" in chronic obstructive pulmonary disease (COPD) by evaluating the effect of body mass index (BMI) on lung function in Chinese patients with COPD. Methods: A total of 1644 patients diagnosed with COPD were recruited from four Chinese tertiary hospitals and were divided into four groups including underweight, normal weight, overweight and obese according to BMI classification standard. The medical data of these patients were collected and used for the multiple linear regression analyses. Results: After adjustment for age, sex, educational level, economic status, smoking status, alcohol consumption, duration of COPD history, events of acute exacerbation in previous year, hypertension, diabetes mellitus, cardiovascular disease, cerebrovascular disease and osteoporosis, BMI had a curvilinear correlation with the forced expiratory volume in the first second (FEV 1 ) in patients with Global Initiative for Obstructive Lung Disease (GOLD) 1– 2 grade (first-order coefficient β, 0.09; 95% CI, 0.03– 0.16; second-order coefficient β, − 0.002; 95% CI, − 0.003–-0.001; P < 0.01). However, BMI had a positive correlation with FEV 1 in patients with GOLD 3– 4 grade (β, 0.01; 95% CI, 0.008– 0.017; P < 0.01) when BMI was used as a quantitative variable. When BMI was used as a qualitative variable, only FEV 1 in overweight group with GOLD 1– 2 grade was significantly higher than that of normal weight group (P< 0.01). Interestingly, both overweight and obese groups had higher FEV 1 in GOLD 3– 4 grade compared with normal weight group (β, 0.06; 95% CI, 0.02– 0.11; β, 0.11; 95% CI, 0.04– 0.18; P< 0.01). The effect of BMI on predicted percentage of FEV 1 (FEV 1 %) was similar to that of FEV 1 in different GOLD grades. Conclusion: Obesity only had a protective effect on lung function in COPD patients with GOLD 3– 4 grade rather than GOLD 1– 2 grade. Trial Registry: ClinicalTrials.gov, No.: NCT 03182309, URL: www.clinicaltrials.gov . Keywords: overweight, obesity